Carvistar 3.125 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of High BP. Other than this, Carvistar 3.125 Tablet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Carvistar 3.125 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Carvistar 3.125 Tablet as well, which are listed below. Normally, these side effects of Carvistar 3.125 Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Carvistar 3.125 Tablet's effect is Moderate during pregnancy and Safe for lactating mothers. In addition, Carvistar 3.125 Tablet's effects on the liver, heart and kidney are discussed below in the Carvistar 3.125 Tablet related warnings section.
Carvistar 3.125 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes, Bradycardia (Slow Heart Rate), Peripheral Vascular Disease (PVD) are examples of such conditions. Other conditions have been mentioned below in the Carvistar 3.125 Tablet contraindications section.
Drug interactions for Carvistar 3.125 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Carvistar 3.125 Tablet is considered not safe while driving, and is not addictive.
Carvistar 3.125 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Carvistar 3.125 Tablet is used -
Severe
Moderate
Mild
Is the use of Carvistar 3.125 Tablet safe for pregnant women?
Carvistar may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Carvistar again without your doctor's advice.
Is the use of Carvistar 3.125 Tablet safe during breastfeeding?
Carvistar does not show any side effects in breastfeeding women.
What is the effect of Carvistar 3.125 Tablet on the Kidneys?
Carvistar is completely safe for kidneys.
What is the effect of Carvistar 3.125 Tablet on the Liver?
Side effects of Carvistar rarely affect the liver.
What is the effect of Carvistar 3.125 Tablet on the Heart?
Side effects of Carvistar rarely affect the heart.
Carvistar 3.125 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Carvistar 3.125 Tablet unless your doctor advises you to do so -
Is this Carvistar 3.125 Tablet habit forming or addictive?
Forming a habit of Carvistar 3.125 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Carvistar 3.125 Tablet, you should not drive or work on any heavy machine, as Carvistar 3.125 Tablet can make you drowsy.
Is it safe?
Yes, but take Carvistar 3.125 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Carvistar 3.125 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Carvistar 3.125 Tablet
Eating certain foods may increase the time it takes Carvistar 3.125 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Carvistar 3.125 Tablet
Consumption of alcohol and Carvistar 3.125 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)